Attenuated mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene

被引:17
|
作者
Gottwald, I. [1 ]
Hughes, J. [2 ]
Stewart, F. [3 ]
Tylee, K. [1 ]
Church, H. [1 ]
Jones, S. A. [1 ]
机构
[1] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester M13 9WL, Lancs, England
[2] Royal Belfast Hosp Sick Children, Metab Off, Belfast BT12 6BE, Antrim, North Ireland
[3] Belfast City Hosp, Belfast BT9 7AB, Antrim, North Ireland
关键词
mucopolysaccharidosis type VI; Maroteaux-Lamy syndrome; attenuated phenotype;
D O I
10.1016/j.ymgme.2011.03.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the case of a boy recently diagnosed with an attenuated form of mucopolysacchararidosis VI (MPS VI, Maroteaux-Lamy syndrome). The Y210C mutation has not been described previously in the homozygous state, although this is a common ARSB mutation. His phenotype is essentially musculoskeletal. Urine screening tests based on measuring total GAG may miss this presentation as total GAGs were not elevated in the patient (although the electrophoresis pattern was clearly abnormal). In this phenotype the benefit of ERT remains to be established. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:300 / 302
页数:3
相关论文
共 50 条
  • [31] Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation
    Hite, SH
    Krivit, W
    Haines, SJ
    Whitley, CB
    PEDIATRIC RADIOLOGY, 1997, 27 (09) : 736 - 738
  • [32] Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)
    Uttarilli, Anusha
    Pasumarthi, Divya
    Ranganath, Prajnya
    Dalal, Ashwin B.
    GENE, 2017, 599 : 19 - 27
  • [33] OCULAR PATHOLOGY OF MAROTEAUX-LAMY SYNDROME (SYSTEMIC MUCOPOLYSACCHARIDOSIS TYPE VI) - HISTOLOGIC AND ULTRASTRUCTURAL REPORT OF 2 CASES
    KENYON, KR
    TOPPING, TM
    MAUMENEE, AE
    GREEN, WR
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1972, 73 (05) : 718 - +
  • [34] MUCOPOLYSACCHARIDOSIS TYPE-VI - (MAROTEAUX-LAMY SYNDROME) .1. SULFATASE-B DEFICIENCY IN TISSUES
    STUMPF, DA
    AUSTIN, JH
    CROCKER, AC
    LAFRANCE, M
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1973, 126 (06): : 747 - 755
  • [35] CLEARING OF THE HOST CORNEA FOLLOWING PENETRATING KERATOPLASTY IN PATIENTS WITH THE MAROTEAUX-LAMY SYNDROME (MUCOPOLYSACCHARIDOSIS TYPE-VI-A)
    NAUMANN, GOH
    RUMMELT, V
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1993, 203 (05) : 351 - 360
  • [36] ATTENUATED PHENOTYPE IN MPS VI (MAROTEAUX-LAMY) PATIENTS CARRYING THE P.R152W MUTATION
    Jurecka, A.
    Zakharova, E.
    Cimbalistiene, L.
    Gusina, N.
    Kulpanovich, A.
    Golda, A.
    Opoka-Winiarska, V
    Piotrowska, E.
    Voskoboeva, E.
    Tylki-Szymanska, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S90 - S90
  • [37] NATURAL HISTORY, DETAILED ANTHROPOMETRIC DATA AND JOINT RANGE OF MOTION OF PATIENTS WITH MAROTEAUX-LAMY SYNDROME (MUCOPOLYSACCHARIDOSIS TYPE VI)
    Jurecka, A.
    Rozdzynska, A.
    Marucha, J.
    Czartoryska, B.
    Tylki-Szymanska, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S136 - S136
  • [38] Pseudo-deficiency allele of the N-acetylgalactosamine-4-sulfatase gene identified in a family with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)
    Sandberg, Sherri
    Deanching, Minerva
    Hoganson, George
    Wenger, David
    Whitley, Chester
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S34 - S34
  • [39] Home treatment of type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome) an alternative at this time of COVID-19 pandemic: A case in Peru
    Cortez Miranda, Jenny Lucy
    Blacido Trujillo, Lincoln
    Liendo Chocano, Maria Elena
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3482 - 3487
  • [40] Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome):: A Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network
    Bradford, TM
    Litjens, T
    Parkinson, EJ
    Hopwood, JJ
    Brooks, DA
    BIOCHEMISTRY, 2002, 41 (15) : 4962 - 4971